John R Mascola Selected Research

John R Mascola Research Topics

Disease

139	Infections 03/2022 - 05/2002
26	Human Influenza (Influenza) 01/2022 - 12/2011
24	COVID-19 04/2022 - 06/2020
17	Viremia 01/2022 - 10/2003
15	Acquired Immunodeficiency Syndrome (AIDS) 12/2021 - 12/2003
14	Virus Diseases (Viral Diseases) 03/2022 - 05/2002
14	HIV Infections (HIV Infection) 01/2022 - 11/2002
7	Communicable Diseases (Infectious Diseases) 01/2022 - 07/2005
5	Persistent Infection 01/2019 - 01/2015
4	Neoplasms (Cancer) 10/2017 - 08/2015
3	Pneumonia (Pneumonitis) 02/2021 - 07/2015
3	Zika Virus Infection 01/2020 - 01/2016
3	Ebola Hemorrhagic Fever 01/2017 - 04/2015
2	Headache (Headaches) 01/2022 - 10/2019
2	Equine Encephalomyelitis (Equine Encephalitis) 01/2022 - 01/2019
2	Malaria 03/2021 - 01/2021
2	Edema (Dropsy) 02/2021 - 01/2021
2	Body Weight (Weight, Body) 01/2021 - 10/2017
2	Syphilis 01/2019 - 11/2003
2	Superinfection 01/2019 - 01/2018
1	Coronavirus Infections 01/2022
1	Venezuelan Equine Encephalomyelitis 01/2022
1	Neutropenia 01/2022
1	Flavivirus Infections 11/2021
1	Asymptomatic Infections 11/2021
1	Weight Loss (Weight Reduction) 10/2021
1	Severe Acute Respiratory Syndrome 10/2021
1	Acute Lung Injury 10/2021
1	Parasitemia 01/2021
1	Inflammation (Inflammations) 10/2020
1	Myalgia 10/2019
1	Chills 10/2019
1	Viral Encephalitis 01/2019
1	Bites and Stings (Sting) 01/2019
1	Paramyxoviridae Infections (Parainfluenza) 11/2018

Drug/Important Bio-Agent (IBA)

94	VaccinesIBA 01/2022 - 11/2002
53	AntibodiesIBA 03/2022 - 05/2002
49	Broadly Neutralizing AntibodiesIBA 01/2022 - 11/2009
40	Neutralizing AntibodiesIBA 12/2021 - 05/2003
24	Monoclonal AntibodiesIBA 04/2022 - 10/2003
23	EpitopesIBA 03/2022 - 04/2005
18	Glycoproteins (Glycoprotein)IBA 10/2019 - 09/2009
17	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 10/2003
15	Hemagglutinins (Hemagglutinin)IBA 01/2022 - 09/2015
13	Antiviral Agents (Antivirals)IBA 01/2021 - 11/2006
11	AntigensIBA 12/2021 - 11/2002
10	Proteins (Proteins, Gene)FDA Link 12/2021 - 11/2002
9	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2022 - 12/2011
7	Immunoglobulins (Immunoglobulin)IBA 01/2020 - 04/2009
6	2019-nCoV Vaccine mRNA-1273IBA 11/2021 - 06/2020
6	AIDS VaccinesIBA 01/2017 - 07/2009
5	RNA (Ribonucleic Acid)IBA 01/2022 - 05/2009
5	Bispecific AntibodiesIBA 10/2021 - 01/2017
5	Polysaccharides (Glycans)IBA 01/2020 - 01/2016
4	Peptides (Polypeptides)IBA 04/2022 - 01/2013
3	Immunoglobulin G (IgG)IBA 11/2019 - 01/2013
3	Indicators and Reagents (Reagents)IBA 10/2017 - 08/2005
3	DNA VaccinesIBA 09/2015 - 07/2005
3	Viral RNAIBA 07/2011 - 11/2003
2	DH1047IBA 01/2022 - 04/2021
2	aluminum sulfate (alum)IBA 01/2022 - 10/2021
2	Biological Warfare AgentsIBA 01/2022 - 02/2015
2	bamlanivimabIBA 12/2021 - 10/2020
2	CytokinesIBA 02/2021 - 01/2021
2	Blocking AntibodiesIBA 02/2021 - 01/2021
2	Fc Receptors (Fc Receptor)IBA 02/2021 - 01/2021
2	Immunoglobulin A (IgA)IBA 11/2019 - 01/2013
2	Ferritins (Ferritin)IBA 01/2019 - 11/2018
2	peptide AIBA 01/2018 - 01/2018
2	Cell Surface ReceptorsIBA 10/2016 - 07/2014
2	Inactivated VaccinesIBA 09/2015 - 08/2013
2	env Gene ProductsIBA 04/2015 - 06/2006
2	GP 140IBA 07/2011 - 04/2009
2	EnzymesIBA 07/2008 - 11/2002
2	ImmunosorbentsIBA 07/2008 - 11/2002
1	Viral ProteinsIBA 01/2022
1	Vorinostat FDA Link 01/2022
1	mRNA VaccinesIBA 12/2021
1	Messenger RNA (mRNA)IBA 12/2021
1	Protein Subunit VaccinesIBA 10/2021
1	keyhole-limpet hemocyanin (keyhole limpet hemocyanin)IBA 03/2021
1	NanovaccinesIBA 01/2021
1	CIS43LSIBA 01/2021
1	Antimalarials (Antimalarial Agents)IBA 01/2021
1	COVID-19 VaccinesIBA 06/2020
1	IgG Receptors (Fc gamma RI)IBA 01/2020
1	SqualeneIBA 01/2019
1	Toll-Like Receptor AgonistsIBA 01/2019
1	Virus-Like Particle VaccinesIBA 01/2019
1	Dihydrotachysterol (AT 10)IBA 10/2017
1	Adenosine Monophosphate (AMP)IBA 01/2017

Therapy/Procedure

14	Therapeutics 01/2022 - 02/2004
3	Aftercare (After-Treatment) 01/2022 - 08/2015
2	Highly Active Antiretroviral Therapy (HAART) 01/2016 - 10/2015
1	Drug Therapy (Chemotherapy) 01/2022
1	Injections 11/2021
1	Intramuscular Injections 11/2021
1	Intravenous Administration 10/2019
1	Art Therapy 01/2019
1	Intravenous Infusions 01/2017